EMERYVILLE, Calif.–(BUSINESS WIRE)– #earnings–Ligand Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Ticker
- [ September 27, 2023 ] Atropos Health Announces Agreement to Accelerate Real World Evidence Generation News
- [ September 27, 2023 ] FDA Grants Breakthrough Device Designation to Gravitas Medical for Neonatal Patients Requiring Enteral Feeding News
- [ September 27, 2023 ] InterVenn Biosciences Welcomes Accomplished Diagnostics Executive Joshua Stahl as CEO News
- [ September 27, 2023 ] Veracyte Names Phillip G. Febbo, M.D., as Chief Scientific Officer and Chief Medical Officer News
- [ September 27, 2023 ] PhenomeX Announces Opto® Memory B Discovery Human Workflow on the Beacon® Optofluidic Platform News
Copyright © 2023 Biotech Networks, LLC
